Appeals Court Blocks Expansion of Fast-Track Deportations in the U.S. 
Judge Dismisses Charges Against Comey and Letitia James After Ruling on Prosecutor’s Appointment 
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate 
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp 
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves 
Dollar Slides to Five-Week Low as Asian Stocks Struggle and Markets Bet on Fed Rate Cut 
Amazon Italy Pays €180M in Compensation as Delivery Staff Probe Ends 
Netanyahu Seeks Presidential Pardon Amid Ongoing Corruption Trial 
Germany’s Economic Recovery Slows as Trade Tensions and Rising Costs Weigh on Growth 
Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand 
Bolsonaro Blames Medication Mix-Up for Ankle Monitor Tampering as Detention Continues 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand 
Australia’s Economic Growth Slows in Q3 Despite Strong Investment Activity 
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines 
U.S. Futures Steady as Rate-Cut Bets Rise on Soft Labor Data 
Johnson & Johnson (J&J) has sued drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs, and at least $25 million in damages from each defendant.
Patients complaining about receiving the wrong pills in their prescription bottles led J&J to discover widespread counterfeiting, as did the voluntary return of hundreds of bottles of counterfeit pharmaceuticals from one of the defendants, distributor ProPharma Distribution LLC.
Following Gilead Sciences Inc.'s lawsuit in January, the firm said it became aware of the sale of counterfeit versions of its HIV medications. Symtuza, a multi-drug combination treatment, as well as Prezcobix, Prezista, and Edurant, are among the medications at issue.
J&J claims that counterfeit bottles occasionally included a different HIV medicine than what was advertised on the label and that one counterfeit bottle contained the strong antipsychotic Seroquel.
The defendants include ProPharma, Safe Chain Solutions LLC, and Scripts Wholesale Inc, as well as drugstore operator I Care Pharmacy 14 and the business' individual proprietors.
According to the lawsuit, I Care Pharmacy had a physical location in New York City that was closed down immediately after a fraudulent transaction was found.
J&J believes the pharmacy is linked to a criminal counterfeiting network that is still operational in New York City, dispensing hazardous counterfeit HIV medication.
